SCHEMBL565042

SCHEMBL565042

COc1ccccc1CCNCC(C)C(=O)N(Cc1cc(Cl)c2c(c1)OCCCO2)CC(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.61
ADRB1 P08588 3/20 0.39
ALDH1A1 P00352 3/20 0.39
PTGES O14684 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.36
TACR1 P25103 1/20 0.36
ADRB2 P07550 2/20 0.35
HPGD P15428 1/20 0.35
ADRB3 P13945 1/20 0.35
MAPK1 P28482 1/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565781 0.92 PROKR2 (0.69) PROKR2ALDH1A1PTGESTACR1HPGD
SCHEMBL564884 0.92 PROKR2 (0.69) PROKR2ALDH1A1PTGESTACR1HPGD
SCHEMBL565126 0.90 PROKR2 (0.64) PROKR2ADRB1ALDH1A1ADRB2MAPK1
SCHEMBL565041 0.86 PROKR2 (0.55) PROKR2ALDH1A1PTGESTACR1HPGD
SCHEMBL565414 0.85 PROKR2 (0.74) PROKR2ALDH1A1KMT2A
SCHEMBL10119945 0.85 PROKR2 (0.70) PROKR2ALDH1A1HPGDMAPK1MEN1
SCHEMBL10106657 0.85 PROKR2 (0.70) PROKR2ALDH1A1HPGDMAPK1MEN1
SCHEMBL565204 0.85 PROKR2 (0.63) PROKR2ALDH1A1MEN1KMT2A
SCHEMBL564583 0.84 PROKR2 (0.63) PROKR2ALDH1A1PTGESPTGDR2MAPK1
SCHEMBL565505 0.84 PROKR2 (0.59) PROKR2ALDH1A1PTGESTACR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885ADRB1 364/4885ALDH1A1 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.